Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers have been used to increase the evidence of underlying Alzheimer’s disease (AD) pathology in mild cognitive impairment (MCI). However, CSF biomarker-based classification often results in conflicting profiles with controversial prognostic value. Normali...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Res Ther
Autors principals: Baldeiras, Inês, Santana, Isabel, Leitão, Maria João, Gens, Helena, Pascoal, Rui, Tábuas-Pereira, Miguel, Beato-Coelho, José, Duro, Diana, Almeida, Maria Rosário, Oliveira, Catarina Resende
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861634/
https://ncbi.nlm.nih.gov/pubmed/29558986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0362-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars